717898 |
CANCERS |
Stereotactic Body Radiotherapy for Patients with Lung Oligometastatic Disease: A Five-Year Review |
2021-07-20 |
10.3390/cancers13143623 |
Virbel Guillaume, Le Fèvre Clara, Noël Georges, Antoni Delphine |
717897 |
CANCERS |
Comment on Hopkins et al. Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial. Cancers 2021, 13, 1176 |
2021-07-20 |
10.3390/cancers13143624 |
Auclin Edouard, Mezquita Laura, Besse Benjamin |
717896 |
CANCERS |
PXR Modulates the Prostate Cancer Cell Response to Afatinib by Regulating the Expression of the Monocarboxylate Transporter SLC16A1 |
2021-07-20 |
10.3390/cancers13143635 |
Matheux Alice, Gassiot Matthieu, Fromont Gaëlle, Leenhardt Fanny, Boulahtouf Abdelhay, Fabbrizio Eric, Marchive Candice, Garcin Aurélie, Agherbi Hanane, Combès Eve, Evrard Alexandre, Houédé Nadine, Balaguer Patrick, Gongora Céline, Mbatchi Litaty C., Pourquier Philippe |
717895 |
CANCERS |
SPTAN1 Expression Predicts Treatment and Survival Outcomes in Colorectal Cancer |
2021-07-20 |
10.3390/cancers13143638 |
Schrecker Christopher, Behrens Sophia, Schönherr Rebecca, Ackermann Anne, Pauli Daniel, Plotz Guido, Zeuzem Stefan, Brieger Angela |
717894 |
CANCERS |
Targeted Next-Generation Sequencing Analysis Predicts the Recurrence in Resected Lung Adenocarcinoma Harboring EGFR Mutations |
2021-07-20 |
10.3390/cancers13143632 |
Kim In Ae, Hur Jae Young, Kim Hee Joung, Lee Song Am, Hwang Jae Joon, Kim Wan Seop, Lee Kye Young |
717893 |
CANCERS |
Two Dimensional-Difference in Gel Electrophoresis (2D-DIGE) Proteomic Approach for the Identification of Biomarkers in Endometrial Cancer Serum |
2021-07-20 |
10.3390/cancers13143639 |
Ura Blendi, Biffi Stefania, Monasta Lorenzo, Arrigoni Giorgio, Battisti Ilaria, Di Lorenzo Giovanni, Romano Federico, Aloisio Michelangelo, Celsi Fulvio, Addobbati Riccardo, Valle Francesco, Rampazzo Enrico, Brucale Marco, Ridolfi Andrea, Licastro Danilo, Ricci Giuseppe |
717892 |
CANCERS |
Rapid Response to the Combination of Lenvatinib and Pembrolizumab in Patients with Advanced Carcinomas (Lung Adenocarcinoma and Malignant Pleural Mesothelioma) |
2021-07-20 |
10.3390/cancers13143630 |
Shalata Walid, Iraqi Muhammed, Bhattacharya Baisali, Fuchs Vered, Roisman Laila C., Cohen Ahron Yehonatan, Massalha Ismaell, Yakobson Alexander, Prasad Manu, Elkabets Moshe, Porgador Angel, Peled Nir |
717891 |
CANCERS |
A Nationwide Study on the Impact of Routine Testing for EGFR Mutations in Advanced NSCLC Reveals Distinct Survival Patterns Based on EGFR Mutation Subclasses |
2021-07-20 |
10.3390/cancers13143641 |
Koopman Bart, Cajiao Garcia Betzabel N., Kuijpers Chantal C. H. J., Damhuis Ronald A. M., van der Wekken Anthonie J., Groen Harry J. M., Schuuring Ed, Willems Stefan M., van Kempen Léon C. |
717890 |
CANCERS |
Characteristics and Lenvatinib Treatment Response of Unresectable Hepatocellular Carcinoma with Iso-High Intensity in the Hepatobiliary Phase of EOB-MRI |
2021-07-20 |
10.3390/cancers13143633 |
Kubo Akinori, Suda Goki, Kimura Megumi, Maehara Osamu, Tokuchi Yoshimasa, Kitagataya Takashi, Ohara Masatsugu, Yamada Ren, Shigesawa Taku, Suzuki Kazuharu, Kawagishi Naoki, Nakai Masato, Sho Takuya, Natsuizaka Mitsuteru, Morikawa Kenichi, Ogawa Koji, Ohnishi Shunsuke, Sakamoto Naoya |
717889 |
CANCERS |
Immunotherapies in Non-Hodgkin’s Lymphoma |
2021-07-20 |
10.3390/cancers13143625 |
Bezombes Christine, Pérez-Galán Patricia |